Prelude Therapeutics (PRLD) Short-term Investments (2021 - 2026)
Prelude Therapeutics' Short-term Investments came in at $125.43 million for Q2 2026, up 164.3% from $47.46 million a year earlier and up 109.8% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Prelude Therapeutics' Short-term Investments was $67.96 million, down 43.9% from FY2024.
- Short-term Investments carries a four-year compound annual growth rate of -28.5% (FY2021 to FY2025).
- Going back by year, Short-term Investments was $121.14 million in FY2024 (-41.7%), $207.64 million in FY2023 (+21.3%), $171.12 million in FY2022 (-34.0%) and $259.41 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Short-term Investments since Q3 2024.
- Year-over-year, Short-term Investments increased in two of the last eight quarters, with an average decline of 23.0%.
- The fastest year-over-year change in Short-term Investments over five years came in Q2 2026 (growth of 164.3%), and the weakest in Q3 2025 (a decline of 94.8%).
- Business Quant data shows PRLD's Short-term Investments at $59.8 million (Q1 2026), $67.96 million (Q4 2025) and $7.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Prelude Therapeutics | 366.99 Mn | -230.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.43 Mn |
| Mar 31, 2026 | 59.80 Mn |
| Dec 31, 2025 | 67.96 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Jun 30, 2025 | 47.46 Mn |
| Mar 31, 2025 | 58.81 Mn |
| Dec 31, 2024 | 121.14 Mn |
| Sep 30, 2024 | 142.49 Mn |
| Jun 30, 2024 | 152.02 Mn |
| Mar 31, 2024 | 177.22 Mn |
| Dec 31, 2023 | 207.64 Mn |
| Sep 30, 2023 | 214.61 Mn |
| Jun 30, 2023 | 228.54 Mn |
| Mar 31, 2023 | 154.05 Mn |
| Dec 31, 2022 | 171.12 Mn |
| Sep 30, 2022 | 172.02 Mn |
| Jun 30, 2022 | 195.60 Mn |
| Mar 31, 2022 | 214.56 Mn |
| Dec 31, 2021 | 259.41 Mn |
| Sep 30, 2021 | 259.44 Mn |
API Access
Prelude Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();